Riskpilot← Back to searchSign inGet full accessDEEPSEAPHARMA ApS
APSActiveCVR 32561365Skanderborgvej 152A, st. tvWholesale of meat, meat products, fish and fish products · NACE 4632Est. 20099 employeesdeepseapharma.dk
Revenue 2025
DKK 4,9M
+26% vs 2024
EBITDA margin
79.3%
+38% vs 2024
Equity ratio
71.6%
Financial strength
Net profit 2025
DKK 3,1M
+40% vs 2024
| Revenue | DKK 4,9M | +26% |
| EBITDA | DKK 3,9M | +38% |
| Net profit | DKK 3,1M | +40% |
| Total assets | DKK 9,8M | +30% |
| Equity | DKK 7M | +50% |
| Employees | 9 | — |
Legal name
DEEPSEAPHARMA ApS
CVR number
32561365
Legal form
Anpartsselskab
NACE code
4632 · Wholesale of meat, meat products, fish and fish products
Founded
6. november 2009
Share capital
DKK 125.000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen
Company purpose
Selskabets formål er at udøve virksomhed med handel med kosttilskud og produkter til personlig pleje samt aktiviteter i tilknytning hertil
Address
Skanderborgvej 152A, st. tv
Phone
+4586986540
Email
info@deepseapharma.dk
Website
deepseapharma.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -22 | 366 | 526 | 548 | 1.236 | 1.102 | 1.261 | 1.790 | 2.157 | 3.089 | 2.589 | 4.435 | 3.909 | 4.911 |
| Staff expenses | -219 | -422 | -515 | -419 | -609 | -581 | -602 | -765 | -945 | -790 | -944 | -825 | -1.083 | -1.016 |
| EBITDA | -242 | -56 | 11 | 129 | 627 | 520 | 659 | 991 | 1.211 | 2.299 | 1.644 | 3.610 | 2.825 | 3.894 |
| Depreciation & amort. | -0 | -0 | 1 | 1 | -0 | -2 | -9 | -25 | -15 | -804 | -801 | -800 | -0 | -0 |
| EBIT | -242 | -56 | 10 | 129 | 627 | 518 | 650 | 966 | 1.197 | 1.496 | 843 | 2.810 | 2.825 | 3.894 |
| Net financials | -4 | -10 | 5 | 3 | 15 | -37 | -30 | -27 | -28 | -56 | -67 | -19 | 58 | 140 |
| Profit before tax | -245 | -66 | 15 | 132 | 641 | 481 | 620 | 939 | 1.169 | 1.440 | 776 | 2.792 | 2.883 | 4.034 |
| Tax | -0 | -0 | -0 | -0 | -5 | 107 | 137 | 209 | 257 | 319 | 171 | 615 | 636 | 889 |
| Net profit | -245 | -66 | 15 | 132 | 646 | 374 | 483 | 730 | 912 | 1.121 | 605 | 2.177 | 2.247 | 3.146 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.871 | 1.704 | 1.324 | 1.137 | 1.468 | 1.999 | 2.464 | 2.274 | 3.539 | 5.198 | 5.041 | 6.657 | 7.547 | 9.796 |
| Equity | -711 | -776 | -761 | -629 | 17 | 391 | 874 | 1.104 | 1.516 | 1.837 | 1.642 | 3.219 | 4.665 | 7.011 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.582 | 2.480 | 2.085 | 1.766 | 1.452 | 1.608 | 1.573 | 1.168 | 2.023 | 3.361 | 3.399 | 3.438 | 2.882 | 2.785 |
| Total debt | 2.582 | 2.480 | 2.085 | 1.766 | 1.452 | 1.608 | 1.573 | 1.168 | 2.023 | 3.361 | 3.399 | 3.438 | 2.882 | 2.785 |
EBITDA margin
79.3%
This company
15.8%
Market median
+402% vs market
20122025
Equity ratio
71.6%
This company
38.2%
Market median
+87% vs market
20122025
Return on equity
44.9%
This company
18.4%
Market median
+144% vs market
20122025
Net profit margin
64.1%
This company
8.1%
Market median
+691% vs market
20122025
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20122025
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TA Management | Management | 2009 | — | — |
KR Management | Management | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DISOP HOLDING ApS | Company | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DISOP HOLDING ApS
DEEPSEAPHARMA ApS Board members of DEEPSEAPHARMA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thorkild Andersen | Management | 0 companies |
| Kristian Rousku Andersen | Management | 0 companies |